Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley Nattel

Showing results (31-40 of 556) with videos related to

Pageof 56
Sort By:
The New England Journal of Medicine|November 16, 2011
Dronedarone in atrial fibrillation--Jekyll and Hyde?Stanley Nattel
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?Stanley Nattel
Circulation Research|August 19, 2017
Allele-Specific Gene Silencing: Another Step in the Inexorable Advance of Gene Therapy for Cardiac Arrhythmia ManagementStanley Nattel
Cardiovascular Research|January 24, 2018
Electrical coupling between cardiomyocytes and fibroblasts: experimental testing of a challenging and important conceptStanley Nattel
The Canadian Journal of Cardiology|September 3, 2013
Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanismsStanley Nattel
European Heart Journal|January 23, 2017
Close connections between contraction and rhythm: a new genetic cause of atrial fibrillation/cardiomyopathy and what it can teach usStanley Nattel
The Canadian Journal of Cardiology|November 14, 2012
Inflammation and biomarkers in vascular disease: emerging insights and opportunitiesStanley Nattel
JACC. Clinical Electrophysiology|November 29, 2023
Atrial Cardiomyopathy Manifestations in the General Population: The Tip or the Iceberg?Stanley Nattel
Circulation Research|June 12, 2004
Defining "culprit mechanisms" in arrhythmogenic cardiac remodelingStanley Nattel
The Canadian Journal of Cardiology|December 31, 2014
Canadian Cardiovascular Society 2014 algorithm for anticoagulation therapy in atrial fibrillation debatedStanley Nattel
Pageof 56

Showing results (31-40 of 556) with videos related to

Sort By:
Pageof 56
The New England Journal of Medicine|November 16, 2011
Dronedarone in atrial fibrillation--Jekyll and Hyde?Stanley Nattel
Nature Clinical Practice. Cardiovascular Medicine|November 3, 2005
Can losartan prevent new-onset atrial fibrillation in hypertensive patients more effectively than atenolol?Stanley Nattel
Circulation Research|August 19, 2017
Allele-Specific Gene Silencing: Another Step in the Inexorable Advance of Gene Therapy for Cardiac Arrhythmia ManagementStanley Nattel
Cardiovascular Research|January 24, 2018
Electrical coupling between cardiomyocytes and fibroblasts: experimental testing of a challenging and important conceptStanley Nattel
The Canadian Journal of Cardiology|September 3, 2013
Paroxysmal atrial fibrillation and pulmonary veins: relationships between clinical forms and automatic versus re-entrant mechanismsStanley Nattel
European Heart Journal|January 23, 2017
Close connections between contraction and rhythm: a new genetic cause of atrial fibrillation/cardiomyopathy and what it can teach usStanley Nattel
The Canadian Journal of Cardiology|November 14, 2012
Inflammation and biomarkers in vascular disease: emerging insights and opportunitiesStanley Nattel
JACC. Clinical Electrophysiology|November 29, 2023
Atrial Cardiomyopathy Manifestations in the General Population: The Tip or the Iceberg?Stanley Nattel
Circulation Research|June 12, 2004
Defining "culprit mechanisms" in arrhythmogenic cardiac remodelingStanley Nattel
The Canadian Journal of Cardiology|December 31, 2014
Canadian Cardiovascular Society 2014 algorithm for anticoagulation therapy in atrial fibrillation debatedStanley Nattel
Pageof 56